Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (1.034.075 €): Der weltweit erste "digitale Datenfingerabdruck" für menschliche Blutproben. Hor 13.03.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Der weltweit erste "digitale Datenfingerabdruck" für menschliche Blutproben.
"Smart4Diagnostics (S4DX) has developed the world’s first “digital human sample data-fingerprint” for human blood samples in pre-preanalytics. We aks for EIC-support to catapult this innovation into a market-changing product. S4DX detects and reduces pre-preanalytical errors at sample collection when patients are still present. This is a quantum leap in quality and safety for patients, doctors and laboratories. They receive reliable results and painful re-visits and re-collection of samples are avoided. With our innovation we change medical diagnostics from ""trust-based” to “evidence-based”. We provide a complete dataset on the quality of each human sample from blood draw until analysis. Our solution provides the new pre-preanalytical data-standard for sensitive medical diagnostics in the future. S4DX “digital human sample fingerprint” will be the necessary data-baseline for highly sensitive tests (e.g. liquid biopsy). Market-entry in Europe with our MVP is planned for Dec. 2020. Our data will be used to refine our pattern-recognition algorithms and thus provide the basis for personalized and precision diagnostics. We collaborate with leading international partners. Roche Diagnostics and Sarstedt are technical advisors, leading European lab chains (Bioscientia/Germany, Medisupport/Switzerland and Certe/ Netherlands) are implementation partners; Würth Electronics provides access to manufacturers and supply chain partners. The company was founded in Jan. 2018, won the EIT-Health Wildcard as best eHealth start-up in Europe, the Hackathon of the TU Munich/Germany as best start-up and was chosen globally by the WHO as one of ten most promising start-ups in 2018. In April 2019 the Investment committee of the High-Tech-Gründerfonds voted unanimously to accept S4DX for further investment of 1 Mio. €, in July 2019 ACI/ Boston accepted us as one of six companies globally in the “Gold-Track-Program” for massive global scaling in healthcare. "
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Smart4Diagnostics GmbH | 1.034.075 € |
Quelle: https://cordis.europa.eu/project/id/945530
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: Smart4Diagnostics GmbH, München.